AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay to identify and neutralize novel targets that control pathologic protein misfolding. Created in 2018, AmyPore owns exclusive patent rights for the therapeutic use of AmyP53, including the development of a nasal spray for treating patients with Alzheimer or Parkinson diseases. Beyond AmyP53, AmyPore is developing a pipeline of therapeutic peptides able to prevent the formation of oligomers implicated in the development and progression of degenerative proteinopathies, including amyotrophic lateral sclerosis (ALS) and type 2 diabetes.
Company Details
- Founded
- -
- Address
- 51, Boulevard Élie Corradi, Septèmes-Les-Vallons,provence-Alpes-Côte D'azur 13240,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.amypore.com
- Keywords
- molecular dynamics simulations, drug design, biological membranes, lipid rafts, gangliosides, cholesterol, calcium imaging, lipid-protein interactions, molecular neurosciences, neurodegenerative diseases, type 2 diabetes, amyloid pores, amyloid oligomers.
- HQ
- Septèmes-les-Vallons, Provence-Alpes-Côte d'Azur
Amypore Questions
Amypore's website is https://www.amypore.com
Amypore's LinkedIn profile is https://fr.linkedin.com/company/amypore
Amypore's industry is
Biotechnology Research
Amypore's top competitors are
Roca Therapeutics,
Volta Medical,
Entent,
Innate Pharma,
Inn'pulse,
Xegen,
Pearcode,
Amypo Technologies Private Limited,
Genxmap,
Bypass Solutions Sas.
Amypore's categories are Biotechnology Research
Amypore's founding year is 2018
